CoreWeave Vs. Nebius: One Runs the U.S. Government’s Debt Playbook, The Other is Like Norway
CoreWeave and Nebius both have more GPU demand than they can handle, but they are financing that growth in ways that could not be more different, and one of those approaches depends on something outside management's control.
Both CoreWeave (NASDAQ:CRWV) and Nebius Group (NASDAQ:NBIS | NBIS Price Prediction) reported Q2 2026 results in August. Both have more demand for GPUs than they can supply. They pay for growth in very different ways. CoreWeave borrows the way Washington does. Nebius looks more like Norway, which builds from cash it already has. CoreWeave shares fell 31.99% in a month, so that funding gap now matters.
CoreWeave’s Interest Bill Swells as Nebius Gets Paid Up Front
CoreWeave’s revenue rose 112% to $2.6 billion, and backlog reached $104.2 billion. That gives it years of visibility. Interest expense also rose to $640 million from $267 million, and Q3 guidance calls for $860 million to $940 million. Debt-to-equity stands at 8.94, which means lenders supply most of the capital. CFO Nitin Agrawal says each cluster ends up “fully repaying asset-level debt used to fund the CapEx.” That only works if every build arrives on schedule.
Nebius increased revenue 454% to $582 million. Prepayments came with 70% of its Q2 deals, covering 50% to 60% of the related capex. In other words, customers fund a large share of the build before the servers go live. Nebius still has debt, though. Its interest expense rose to $119.1M from $4.8M.
| Business Driver | CoreWeave | Nebius |
|---|---|---|
| Main Funding Source | Asset-level debt and term loans | Prepayments, converts, equity |
| Contracted Power | 4.2 gigawatts | Target of 5 gigawatts by year-end |
| Higher-Margin Push | Managed inference | Token Factory, auctions |
CoreWeave Sells Years Ahead While Nebius Sells Its Scarcity
CoreWeave prefers long contracts. In July it raised prices about 25% across SKUs and signed an A100 deal that runs to 2029. That shows older chips still earn money. Managed inference now brings in more than $100 million of annualized revenue, a small but promising source of margin.
Nebius is holding capacity back on purpose. Arkady Volozh said, “We could sell today our entire 2027 capacity on these terms if we wanted to. But we are not doing this.” Its first capacity auction closed 15% above its previous highest price. That patience costs shareholders something: Nebius sold 12.7 million shares through its at-the-market program at $224 each.
Credit Markets Will Decide Who Keeps Building
CoreWeave expects to spend $35 billion to $39 billion on capex this year. Short sellers modeled on The Big Short are now publicly targeting it, and Bloomberg called its sell-off a warning sign for the broader market. The key question is whether adjusted operating margins reach the low teens in Q4 as promised. For Nebius, customer concentration is worth monitoring. Three clients made up 24%, 21%, and 14% of revenue.
Why Nebius’ Norway Model Wins My Preference
I like CoreWeave’s operational lead, and a backlog that large is real. Still, its model depends on credit staying open and cheap. If lenders pull back, the math gets harder quickly. Nebius has a balance sheet showing $8.042B in cash and almost no corporate-level debt, which gives it room to wait. I would accept some dilution in exchange for that flexibility. If CoreWeave’s interest costs flatten while margins widen, my view would change.
Contact [email protected] for any questions or corrections.





